EP207: Disrupt or Be Disrupted, With A.G. Breitenstein, Partner at Optum Ventures
About this episode
A.G. is a partner at Optum Ventures. She was most recently the co-founder and chief product officer at Humedica, one of the earliest big-data analytics companies in health care. Following its acquisition by Optum, she became chief product officer at Optum Analytics. She began her career as an attorney, founding a non-profit aimed at helping homeless youth at high-risk for HIV infection. A.G. expanded her mission by obtaining a degree in public health from Harvard. She is a mission-driven leader focused on transforming the health care system into a health system.
Get every episode summarized
Each time Relentless Health Value publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Relentless Health Value

Private Equity in Primary Care: What the Data Actually Shows, With Yashaswini Si...
Relentless Health Value

Why Should a Plan Sponsor Care About the 340B Charity Program? With Shawn Gremmi...
Relentless Health Value

Mark Cuban and Cora Opsahl: The Truth About Pass-Through PBM Contracts and Gener...
Relentless Health Value

PMPM vs FFS—The Perverse Incentives Plan Sponsors Sometimes Miss, With Cristin D...
Relentless Health Value